IBN Stock Analysis: ICICI Bank | NYSE
Banks - Regional | NYSE, USA | Market Cap: 106.040m USD | 12M Return: -4.6% | US45104G1040 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 142M
EPS Trend: 91.0%
Qual. Beats: 2
Rev. Trend: 88.9%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
ICICI Bank Limited is an Indian financial services group that provides a wide range of banking and related services to retail and corporate customers in India and abroad. Its operations are organized across multiple segments, including Retail Banking, Wholesale Banking, Treasury, Life Insurance, General Insurance, and Other Banking activities. Founded in 1955 and headquartered in Mumbai, the bank is listed in the U.S. through ADRs trading on the NYSE under the ticker IBN.
The companys offerings span the full retail and commercial banking stack: deposit accounts (savings, salary, current, fixed, and foreign currency accounts), lending products (home, auto, personal, education, gold, commercial, working capital, and trade finance), credit and debit cards, digital wallets, investment and broking services, and wealth management. Beyond traditional banking, ICICI also provides life and general insurance, asset management, custodial services, trusteeship, and venture capital fund management, making it one of Indias large diversified private-sector banks.
Indian diversified banks like ICICI typically derive revenue from a mix of net interest income (the gap between loan and deposit rates) and fee-based income from cards, distribution, transaction banking, and insurance, which helps diversify earnings across the credit cycle. The Indian banking sector remains structurally supported by a large under-banked retail population, growing credit penetration, and the countrys broader role as an emerging-market financial center.
- RBI rate cuts compress net interest margins on lending portfolio
- Retail loan growth accelerates in mortgages and personal credit
- Insurance subsidiaries deliver rising fee income and dividends
| Net Income: 591b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.96 > 1.0 |
| NWC/Revenue: -498.5% < 20% (prev -484.5%; Δ -13.95% < -1%) |
| CFO/TA 0.02 > 3% & CFO 673b > Net Income 591b |
| Net Debt (204b) to EBITDA (864b): 0.24 < 3 |
| Current Ratio: 0.15 > 1.5 & < 3 |
| Outstanding Shares: last quarter (3.63b) vs 12m ago 0.22% < -2% |
| Gross Margin: 68.58% > 18% (prev 68.62%; Δ -0.04% > 0.5%) |
| Asset Turnover: 10.40% > 50% (prev 11.36%; Δ -0.96% > 0%) |
| Interest Coverage Ratio: 0.90 > 6 (EBIT TTM 833b / Interest Expense TTM 928b) |
| A: -0.47 (Total Current Assets 2765b - Total Current Liabilities 18300b) / Total Assets 33074b |
| B: 0.04 (Retained Earnings 1483b / Total Assets 33074b) |
| C: 0.03 (EBIT TTM 833b / Avg Total Assets 29969b) |
| D: 0.14 (Book Value of Equity 3922b / Total Liabilities 28954b) |
| Altman-Z'' = -2.61 = D |
As of October 25, 2026, the stock is trading at USD 29.46 with a total of 4,796,863 shares traded. Over the past week, the price has changed by -1.77%, over one month by +5.55%, over three months by +1.60% and over the past year by -4.60%.
Current recommended Stop Loss: 28.60 (which is 2.9% or 1.6 ATR below the current price).
ICICI Bank has received a consensus analysts rating of 4.75. Therefore, it is recommended to buy IBN.
- StrongBuy: 3
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 37.8 | 28.1% |
Market Cap TWD = 3454b (106b USD * 32.571 USD.TWD)
P/E Trailing = 17.2749
P/E Forward = 16.6113
P/S = 0.05
P/B = 2.5392
P/EG = 0.5248
Revenue TTM = 3117b TWD
EBIT TTM = 833b TWD
EBITDA TTM = 864b TWD
Long Term Debt = 2203b TWD (from longTermDebt, last fiscal year)
Short Term Debt = 245b TWD (from shortLongTermDebt, last fiscal year)
Debt = 2969b TWD (from shortLongTermDebtTotal, last quarter)
Net Debt = 204b TWD (calculated: Debt 2969b - CCE 2765b)
Enterprise Value = 3658b TWD (3454b + Debt 2969b - CCE 2765b)
Interest Coverage Ratio = 0.90 (Ebit TTM 833b / Interest Expense TTM 928b)
EV/FCF = 5.75x (Enterprise Value 3658b / FCF TTM 636b)
FCF Yield = 17.39% (FCF TTM 636b / Enterprise Value 3658b)
FCF Margin = 20.41% (FCF TTM 636b / Revenue TTM 3117b)
Net Margin = 18.98% (Net Income TTM 591b / Revenue TTM 3117b)
Gross Margin = 68.58% ((Revenue TTM 3117b - Cost of Revenue TTM 979b) / Revenue TTM)
Gross Margin QoQ = 69.91% (prev 60.34%)
Tobins Q-Ratio = 0.11 (Enterprise Value 3658b / Total Assets 33074b)
Interest Expense / Debt = 31.26% (Interest Expense 928b / Debt 2969b)
Taxrate = 24.49% (204b / 833b)
NOPAT = 629b (EBIT 833b * (1 - 24.49%))
Current Ratio = 0.15 (Total Current Assets 2765b / Total Current Liabilities 18300b)
Debt / Equity = 0.76 (Debt 2969b / totalStockholderEquity, last quarter 3922b)
Debt / EBITDA = 0.24 (Net Debt 204b / EBITDA 864b)
Debt / FCF = 0.32 (Net Debt 204b / FCF TTM 636b)
Total Stockholder Equity = 3711b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.97% (Net Income 591b / Total Assets 33074b)
RoE = 15.94% (Net Income TTM 591b / Total Stockholder Equity 3711b)
RoCE = 14.09% (EBIT 833b / Capital Employed (Equity 3711b + L.T.Debt 2203b))
RoIC = 4.30% (NOPAT 629b / Invested Capital 14618b)
WACC = 14.37% (E(3454b)/V(6422b) * Re(6.44%) + D(2969b)/V(6422b) * Rd(31.26%) * (1-Tc(0.24)))
Discount Rate = 6.44% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 88.68 | Cagr: 0.59%
[DCF] Terminal Value 54.14% ; FCFF base≈691b ; Y1≈606b ; Y5≈490b
[DCF] Fair Price = 1.05k (EV 3990b - Net Debt 204b = Equity 3786b / Shares 3.59b; r=14.37% [WACC]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 91.00 | EPS CAGR: 6.47% | SUE: 3.48 | # QB: 2
Revenue Correlation: 88.89 | Revenue CAGR: 13.67% | SUE: 0.83 | # QB: 0
EPS current Quarter (2026-12-31): EPS=0.45 | Chg30d=+15.89% | Revisions=+25% | Analysts=1
EPS current Year (2027-03-31): EPS=1.73 | Chg30d=+7.82% | Revisions=-25% | GrowthEPS=+15.8% | GrowthRev=+16.3%
EPS next Year (2028-03-31): EPS=2.01 | Chg30d=+8.11% | Revisions=+0% | GrowthEPS=+16.1% | GrowthRev=+17.9%
[Analyst] Revisions Ratio: +0% (up=1, down=1)